nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—hematopoietic system—anemia	0.0194	0.0563	CbGeAlD
Carfilzomib—PSMB10—lymphoid tissue—anemia	0.0136	0.0397	CbGeAlD
Carfilzomib—PSMB10—digestive system—anemia	0.0135	0.0392	CbGeAlD
Carfilzomib—PSMB10—blood—anemia	0.0128	0.0373	CbGeAlD
Carfilzomib—PSMB10—endocrine gland—anemia	0.0111	0.0324	CbGeAlD
Carfilzomib—PSMB1—embryo—anemia	0.0108	0.0314	CbGeAlD
Carfilzomib—PSMB2—embryo—anemia	0.0105	0.0306	CbGeAlD
Carfilzomib—PSMB5—nephron tubule—anemia	0.0103	0.0299	CbGeAlD
Carfilzomib—PSMB10—liver—anemia	0.01	0.0292	CbGeAlD
Carfilzomib—PSMB8—cortex of kidney—anemia	0.00996	0.029	CbGeAlD
Carfilzomib—PSMB1—hematopoietic system—anemia	0.00963	0.028	CbGeAlD
Carfilzomib—PSMB2—hematopoietic system—anemia	0.0094	0.0273	CbGeAlD
Carfilzomib—PSMB1—nephron tubule—anemia	0.00899	0.0261	CbGeAlD
Carfilzomib—PSMB5—cortex of kidney—anemia	0.0088	0.0256	CbGeAlD
Carfilzomib—PSMB2—nephron tubule—anemia	0.00877	0.0255	CbGeAlD
Carfilzomib—PSMB8—blood—anemia	0.00827	0.024	CbGeAlD
Carfilzomib—PSMB8—bone marrow—anemia	0.008	0.0233	CbGeAlD
Carfilzomib—PSMB1—kidney—anemia	0.0079	0.023	CbGeAlD
Carfilzomib—PSMB2—kidney—anemia	0.0077	0.0224	CbGeAlD
Carfilzomib—PSMB1—cortex of kidney—anemia	0.00769	0.0224	CbGeAlD
Carfilzomib—PSMB2—cortex of kidney—anemia	0.0075	0.0218	CbGeAlD
Carfilzomib—PSMB1—gonad—anemia	0.00732	0.0213	CbGeAlD
Carfilzomib—PSMB5—blood—anemia	0.0073	0.0212	CbGeAlD
Carfilzomib—PSMB2—gonad—anemia	0.00715	0.0208	CbGeAlD
Carfilzomib—PSMB5—bone marrow—anemia	0.00707	0.0206	CbGeAlD
Carfilzomib—PSMB1—lymphoid tissue—anemia	0.00678	0.0197	CbGeAlD
Carfilzomib—PSMB1—digestive system—anemia	0.0067	0.0195	CbGeAlD
Carfilzomib—PSMB2—lymphoid tissue—anemia	0.00662	0.0192	CbGeAlD
Carfilzomib—PSMB2—digestive system—anemia	0.00654	0.019	CbGeAlD
Carfilzomib—PSMB8—liver—anemia	0.00646	0.0188	CbGeAlD
Carfilzomib—PSMB1—blood—anemia	0.00638	0.0186	CbGeAlD
Carfilzomib—PSMB2—blood—anemia	0.00623	0.0181	CbGeAlD
Carfilzomib—PSMB1—bone marrow—anemia	0.00618	0.018	CbGeAlD
Carfilzomib—PSMB2—bone marrow—anemia	0.00603	0.0175	CbGeAlD
Carfilzomib—PSMB5—liver—anemia	0.00571	0.0166	CbGeAlD
Carfilzomib—PSMB1—endocrine gland—anemia	0.00554	0.0161	CbGeAlD
Carfilzomib—PSMB2—endocrine gland—anemia	0.0054	0.0157	CbGeAlD
Carfilzomib—PSMB1—liver—anemia	0.00499	0.0145	CbGeAlD
Carfilzomib—PSMB2—liver—anemia	0.00487	0.0142	CbGeAlD
Carfilzomib—Lopinavir—CYP1A2—anemia	0.00332	0.543	CrCbGaD
Carfilzomib—Ritonavir—CYP1A2—anemia	0.00279	0.457	CrCbGaD
Carfilzomib—ABCB1—blood plasma—anemia	0.0026	0.00755	CbGeAlD
Carfilzomib—ABCB1—embryo—anemia	0.00161	0.00468	CbGeAlD
Carfilzomib—ABCB1—hematopoietic system—anemia	0.00144	0.00418	CbGeAlD
Carfilzomib—ABCB1—nephron tubule—anemia	0.00134	0.0039	CbGeAlD
Carfilzomib—ABCB1—kidney—anemia	0.00118	0.00342	CbGeAlD
Carfilzomib—ABCB1—cortex of kidney—anemia	0.00115	0.00333	CbGeAlD
Carfilzomib—ABCB1—gonad—anemia	0.00109	0.00318	CbGeAlD
Carfilzomib—ABCB1—lymphoid tissue—anemia	0.00101	0.00294	CbGeAlD
Carfilzomib—ABCB1—digestive system—anemia	0.000999	0.0029	CbGeAlD
Carfilzomib—ABCB1—blood—anemia	0.000951	0.00277	CbGeAlD
Carfilzomib—ABCB1—bone marrow—anemia	0.000921	0.00268	CbGeAlD
Carfilzomib—ABCB1—endocrine gland—anemia	0.000825	0.0024	CbGeAlD
Carfilzomib—ABCB1—liver—anemia	0.000744	0.00216	CbGeAlD
Carfilzomib—ABCB1—Metabolism—SLC46A1—anemia	7.68e-05	0.000118	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—RHAG—anemia	7.68e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PDGFRB—anemia	7.67e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PARP1—anemia	7.66e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PARP1—anemia	7.66e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PARP1—anemia	7.66e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—C3—anemia	7.65e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—C3—anemia	7.65e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—C3—anemia	7.65e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-A—anemia	7.63e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-A—anemia	7.63e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-A—anemia	7.63e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PARP1—anemia	7.55e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—C3—anemia	7.54e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-A—anemia	7.52e-05	0.000116	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AGT—anemia	7.42e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AGT—anemia	7.38e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CSF2—anemia	7.3e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CRP—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CRP—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CRP—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AMN—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SUCLA2—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSS—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DHODH—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NT5C3A—anemia	7.28e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CSF2—anemia	7.27e-05	0.000112	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CBL—anemia	7.2e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CBL—anemia	7.2e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CBL—anemia	7.2e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PDGFRB—anemia	7.18e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—HMOX1—anemia	7.18e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—HMOX1—anemia	7.18e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—HMOX1—anemia	7.18e-05	0.000111	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CRP—anemia	7.18e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PDGFRB—anemia	7.15e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL3—anemia	7.12e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL3—anemia	7.12e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL3—anemia	7.12e-05	0.00011	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CBL—anemia	7.1e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—HMOX1—anemia	7.08e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—MTHFR—anemia	7.06e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—MTHFR—anemia	7.06e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—MTHFR—anemia	7.06e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TERT—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TERT—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TERT—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—HLA-A—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—HLA-A—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—HLA-A—anemia	7.04e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL3—anemia	7.02e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DRB1—anemia	6.97e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DRB1—anemia	6.97e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DRB1—anemia	6.97e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—MTHFR—anemia	6.96e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TERT—anemia	6.95e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—HLA-A—anemia	6.95e-05	0.000107	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AK1—anemia	6.94e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DRB1—anemia	6.87e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—JAK2—anemia	6.84e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—JAK2—anemia	6.81e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—anemia	6.72e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GSTM1—anemia	6.69e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GSTM1—anemia	6.69e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GSTM1—anemia	6.69e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—anemia	6.69e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PRL—anemia	6.68e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PRL—anemia	6.68e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PRL—anemia	6.68e-05	0.000103	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYB5A—anemia	6.66e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GSTM1—anemia	6.6e-05	0.000102	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PRL—anemia	6.59e-05	0.000101	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—C3—anemia	6.53e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TERT—anemia	6.51e-05	0.0001	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—C3—anemia	6.5e-05	9.99e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—anemia	6.49e-05	9.98e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TERT—anemia	6.48e-05	9.96e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—anemia	6.46e-05	9.93e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—TF—anemia	6.45e-05	9.92e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—KIT—anemia	6.43e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—KIT—anemia	6.43e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—KIT—anemia	6.43e-05	9.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—KIT—anemia	6.34e-05	9.75e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—JAK2—anemia	6.32e-05	9.72e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—JAK2—anemia	6.29e-05	9.67e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AGT—anemia	6.2e-05	9.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC4A1—anemia	6.19e-05	9.52e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NDUFA2—anemia	6.19e-05	9.52e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBA2—anemia	6.19e-05	9.52e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—TFRC—anemia	6.19e-05	9.51e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AGT—anemia	6.17e-05	9.49e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KITLG—anemia	6.09e-05	9.37e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KITLG—anemia	6.09e-05	9.37e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KITLG—anemia	6.09e-05	9.37e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KITLG—anemia	6.01e-05	9.24e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—anemia	5.99e-05	9.22e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—anemia	5.99e-05	9.21e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—anemia	5.97e-05	9.18e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—anemia	5.96e-05	9.17e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—anemia	5.96e-05	9.17e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—anemia	5.94e-05	9.14e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—KIT—anemia	5.94e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—KIT—anemia	5.94e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—KIT—anemia	5.94e-05	9.13e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF2—anemia	5.93e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF2—anemia	5.93e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF2—anemia	5.93e-05	9.12e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MTHFR—anemia	5.92e-05	9.1e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MTHFR—anemia	5.92e-05	9.1e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MTHFR—anemia	5.92e-05	9.1e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—KIT—anemia	5.85e-05	9e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF2—anemia	5.84e-05	8.99e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MTHFR—anemia	5.83e-05	8.97e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—F2—anemia	5.73e-05	8.81e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—F2—anemia	5.7e-05	8.77e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—anemia	5.69e-05	8.75e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—anemia	5.66e-05	8.71e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SEC24B—anemia	5.66e-05	8.71e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AGT—anemia	5.62e-05	8.65e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AGT—anemia	5.62e-05	8.65e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AGT—anemia	5.62e-05	8.65e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AGT—anemia	5.54e-05	8.52e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CSF2—anemia	5.53e-05	8.51e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CSF2—anemia	5.53e-05	8.51e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CSF2—anemia	5.53e-05	8.51e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPI—anemia	5.52e-05	8.48e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KIT—anemia	5.48e-05	8.44e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KIT—anemia	5.46e-05	8.4e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CSF2—anemia	5.46e-05	8.39e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PDGFRB—anemia	5.44e-05	8.38e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PDGFRB—anemia	5.44e-05	8.38e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PDGFRB—anemia	5.44e-05	8.38e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—LPIN2—anemia	5.38e-05	8.28e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PDGFRB—anemia	5.37e-05	8.26e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBB—anemia	5.26e-05	8.09e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ACSL4—anemia	5.26e-05	8.09e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—JAK2—anemia	5.19e-05	7.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—JAK2—anemia	5.19e-05	7.98e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—JAK2—anemia	5.19e-05	7.98e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—JAK2—anemia	5.11e-05	7.87e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—anemia	5.09e-05	7.83e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—anemia	5.09e-05	7.83e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—anemia	5.09e-05	7.83e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PGK1—anemia	5.04e-05	7.76e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—UMPS—anemia	5.04e-05	7.76e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—anemia	5.02e-05	7.72e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—BRIP1—anemia	4.95e-05	7.61e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—C3—anemia	4.95e-05	7.61e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—C3—anemia	4.95e-05	7.61e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—C3—anemia	4.95e-05	7.61e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TERT—anemia	4.93e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TERT—anemia	4.93e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TERT—anemia	4.93e-05	7.59e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—anemia	4.92e-05	7.56e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—anemia	4.92e-05	7.56e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—anemia	4.92e-05	7.56e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—C3—anemia	4.88e-05	7.5e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TERT—anemia	4.86e-05	7.48e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CUBN—anemia	4.86e-05	7.47e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSR—anemia	4.86e-05	7.47e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—anemia	4.85e-05	7.46e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—JAK2—anemia	4.79e-05	7.37e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—JAK2—anemia	4.79e-05	7.37e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—JAK2—anemia	4.79e-05	7.37e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—JAK2—anemia	4.72e-05	7.26e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGT—anemia	4.7e-05	7.23e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGT—anemia	4.7e-05	7.23e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGT—anemia	4.7e-05	7.23e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TCN2—anemia	4.69e-05	7.21e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PKLR—anemia	4.69e-05	7.21e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGT—anemia	4.63e-05	7.13e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALAS1—anemia	4.54e-05	6.99e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—anemia	4.54e-05	6.98e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—anemia	4.52e-05	6.96e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—anemia	4.52e-05	6.96e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—anemia	4.52e-05	6.96e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—HMOX1—anemia	4.51e-05	6.94e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—anemia	4.48e-05	6.89e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—anemia	4.48e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADA—anemia	4.47e-05	6.88e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—anemia	4.46e-05	6.86e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—JAK2—anemia	4.42e-05	6.81e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—JAK2—anemia	4.4e-05	6.77e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—F2—anemia	4.34e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—F2—anemia	4.34e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—F2—anemia	4.34e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—anemia	4.31e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—anemia	4.31e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—anemia	4.31e-05	6.64e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SEC23A—anemia	4.29e-05	6.6e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—F2—anemia	4.28e-05	6.59e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—anemia	4.25e-05	6.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—G6PD—anemia	4.18e-05	6.43e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KIT—anemia	4.16e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KIT—anemia	4.16e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KIT—anemia	4.16e-05	6.39e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KIT—anemia	4.1e-05	6.3e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—anemia	4.03e-05	6.2e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TPI1—anemia	3.99e-05	6.13e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—anemia	3.86e-05	5.94e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—anemia	3.84e-05	5.91e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MAOB—anemia	3.82e-05	5.88e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—UGT1A1—anemia	3.75e-05	5.77e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—A2M—anemia	3.55e-05	5.47e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—anemia	3.51e-05	5.4e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—anemia	3.49e-05	5.37e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALDOA—anemia	3.44e-05	5.29e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—JAK2—anemia	3.35e-05	5.16e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—JAK2—anemia	3.35e-05	5.16e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—JAK2—anemia	3.35e-05	5.16e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—JAK2—anemia	3.31e-05	5.09e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—anemia	3.24e-05	4.98e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—anemia	3.22e-05	4.96e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBA1—anemia	3.17e-05	4.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTT1—anemia	3.09e-05	4.76e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCLC—anemia	3.06e-05	4.7e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DHFR—anemia	2.96e-05	4.55e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—anemia	2.92e-05	4.5e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—anemia	2.92e-05	4.5e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—anemia	2.92e-05	4.5e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—anemia	2.88e-05	4.44e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT2—anemia	2.76e-05	4.25e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—anemia	2.71e-05	4.17e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—anemia	2.66e-05	4.09e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—anemia	2.66e-05	4.09e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—anemia	2.66e-05	4.09e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—anemia	2.62e-05	4.03e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP1A2—anemia	2.57e-05	3.95e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NQO1—anemia	2.57e-05	3.95e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—anemia	2.45e-05	3.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—anemia	2.45e-05	3.78e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—anemia	2.45e-05	3.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—anemia	2.42e-05	3.72e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GOT1—anemia	2.39e-05	3.67e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—anemia	2.27e-05	3.49e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—anemia	2.26e-05	3.47e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HMOX1—anemia	2.11e-05	3.25e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GSTM1—anemia	1.97e-05	3.03e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MTHFR—anemia	1.74e-05	2.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—anemia	1.72e-05	2.64e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—anemia	1.72e-05	2.64e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—anemia	1.72e-05	2.64e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—anemia	1.69e-05	2.61e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—anemia	1.65e-05	2.54e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—anemia	1.27e-05	1.95e-05	CbGpPWpGaD
